[1] |
de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis[J]. Lancet Oncol, 2012,13(6): 607-15.
|
[2] |
Dudich E, Semenkova L, Gorbatova E, et al. Growth-regulative activity of human alpha- fetoprotein for different types of tumor and normal cells[J]. Tumor Biol, 1998,19(1): 30-40.
|
[3] |
Li M, Li H, Li C, et al. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells[J]. Cancer Lett, 2009, 285(2): 19 0-9.
|
[4] |
Wang S, Jiang W, Chen X, et al. Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma[J]. J Hepatol, 2012,57(2): 322-9.
|
[5] |
Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4[J]. Semin Cancer Biol, 2004,14(3): 17 1-9.
|
[6] |
Kim SW, Kim HY, Song IC,et al. Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines[J]. Cancer Res Treat, 20 08,40(2): 53-61.
|
[7] |
Peng SB, Peek V, Zhai Y, et al. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1α/ CXCR4-mediated migration of epitheloid carcinoma cells[J]. Mol Cancer Res, 2005,3(4): 227-36.
|
[8] |
Li M, Li H, Li C, et al. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines[J]. Int J Cancer, 2011, 12 8(3): 524-32.
|
[9] |
Sambrook J, Frit sch EF, Manitis T. Molecular cloning: a laboratory mannul[M]. 2nd Editor. New York: Cold Spring Harbor Laboratory Press, 1989:1322-30.
|
[10] |
Duda DG, Kozin SV, Kirkpatrick ND, et al. CXCL12 (SDF1α)- CXCR4/CXCR7 Pathway inhibition: An emerging sensitizer for anticancer therapies? [J]. Clin Cancer Res, 2011,17(8): 2074-80.
|
[11] |
Xiang Z, Zeng Z, Tang Z, et al. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome[J]. Cancer J, 2009,15(6): 519-25.
|
[12] |
Chen G, Chen S, Wang X, et al. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells[J]. J Biol Chem, 2012,287(15): 12132-41.
|
[13] |
De Clercq E. The bicyclam AMD3100 story[J]. Nat Rev Drug Discov, 2003,2(7):581-7.
|
[14] |
Li M, Li H, Li C, et al. Alpha fetoprotein is a novel proteinbinding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells[J]. Int J Cancer, 2009, 124(12): 28 45-54.
|
[15] |
Li MS, Li PF, He SP, et al. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line[J]. World J Gastroenterol, 2002,8(3): 469-75.
|
[16] |
Wang XW, Xie H. Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro[J]. Life Sci, 1999,64(1): 17-23.
|